- Home
- SABS vs AMST Comparison
SABS vs AMST Comparison
Compare SABS & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- AMST
- Stock Information
- Founded
- SABS 2014
- AMST 2017
- Country
- SABS United States
- AMST United States
- Employees
- SABS N/A
- AMST N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- SABS Health Care
- AMST Technology
- Exchange
- SABS Nasdaq
- AMST Nasdaq
- Market Cap
- SABS 15.8M
- AMST 13.3M
- IPO Year
- SABS N/A
- AMST 2020
- Fundamental
- Price
- SABS $2.02
- AMST $2.83
- Analyst Decision
- SABS Strong Buy
- AMST
- Analyst Count
- SABS 5
- AMST 0
- Target Price
- SABS $10.00
- AMST N/A
- AVG Volume (30 Days)
- SABS 4.3M
- AMST 45.4K
- Earning Date
- SABS 08-07-2025
- AMST 09-29-2025
- Dividend Yield
- SABS N/A
- AMST N/A
- EPS Growth
- SABS N/A
- AMST N/A
- EPS
- SABS N/A
- AMST N/A
- Revenue
- SABS $114,698.00
- AMST $82,544.00
- Revenue This Year
- SABS N/A
- AMST N/A
- Revenue Next Year
- SABS N/A
- AMST N/A
- P/E Ratio
- SABS N/A
- AMST N/A
- Revenue Growth
- SABS N/A
- AMST N/A
- 52 Week Low
- SABS $1.00
- AMST $2.00
- 52 Week High
- SABS $6.60
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- SABS 42.28
- AMST 41.47
- Support Level
- SABS $1.85
- AMST $2.78
- Resistance Level
- SABS $2.26
- AMST $3.02
- Average True Range (ATR)
- SABS 0.26
- AMST 0.17
- MACD
- SABS -0.06
- AMST -0.04
- Stochastic Oscillator
- SABS 16.71
- AMST 13.85
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.